ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 75 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $344,000 | +1.5% | 109,231 | -16.2% | 0.00% | – |
Q4 2016 | $339,000 | -29.7% | 130,335 | +5.2% | 0.00% | – |
Q3 2016 | $482,000 | +44.7% | 123,926 | 0.0% | 0.00% | – |
Q2 2016 | $333,000 | +21.5% | 123,926 | +91.7% | 0.00% | – |
Q2 2015 | $274,000 | -17.7% | 64,632 | -25.0% | 0.00% | – |
Q1 2015 | $333,000 | -42.6% | 86,154 | 0.0% | 0.00% | – |
Q4 2014 | $580,000 | +10.3% | 86,154 | -10.0% | 0.00% | – |
Q3 2014 | $526,000 | -45.1% | 95,724 | +2.4% | 0.00% | -100.0% |
Q2 2014 | $958,000 | -7.7% | 93,505 | +8.2% | 0.00% | 0.0% |
Q1 2014 | $1,038,000 | -22.1% | 86,404 | -26.7% | 0.00% | 0.0% |
Q4 2013 | $1,333,000 | +5.0% | 117,837 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $1,269,000 | +23.2% | 117,837 | +6.0% | 0.00% | 0.0% |
Q2 2013 | $1,030,000 | – | 111,117 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 12,528,120 | $38,210,000 | 1.53% |
Cormorant Asset Management, LP | 850,000 | $2,593,000 | 0.41% |
Palo Alto Investors LP | 1,656,644 | $5,053,000 | 0.24% |
Granahan Investment Management | 1,745,604 | $5,324,000 | 0.16% |
Spark Investment Management LLC | 318,500 | $980,000 | 0.13% |
Opus Point Partners Management, LLC | 57,747 | $176,000 | 0.10% |
SHEPHERD KAPLAN KROCHUK, LLC | 76,472 | $233,000 | 0.06% |
Joel Isaacson & Co., LLC | 70,660 | $216,000 | 0.06% |
MYCIO WEALTH PARTNERS, LLC | 75,000 | $229,000 | 0.05% |
Cornerstone Capital, Inc. | 59,200 | $181,000 | 0.04% |